{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:05:40Z","timestamp":1781143540771,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>This case report details the clinical course of a 16-year-old female student with<jats:italic>Mycoplasma pneumoniae<\/jats:italic>infection complicated by autoimmune encephalitis, spanning from 6 February 2022, to 12 April 2022, with a one-year follow-up. The patient presented with a two-week history of cough and fever, followed by altered consciousness and neuropsychiatric symptoms, including hyperactivity and incoherent speech. Despite normal brain MRI findings, cerebrospinal fluid (CSF) analysis confirmed<jats:italic>Mycoplasma pneumoniae<\/jats:italic>with titers of, and positive IgLON5 antibodies. Initial treatment included azithromycin, ceftriaxone, and acyclovir, followed by mechanical ventilation and ECMO due to respiratory failure. The antibiotic regimen was switched to intravenous omadacycline based on genetic testing results. Autoimmune encephalitis was managed with intravenous methylprednisolone, intravenous immunoglobulin (IVIG), and plasma exchange. The patient\u2019s condition improved, and she was discharged on 12 March 2022, with normal cognitive and behavioral functions. However, she was readmitted one month later due to cognitive decline and sleep disturbances, with a Mini-Mental State Examination (MMSE) score of 20\/30 and a modified Rankin Scale (mRS) score of 3. At the one-year follow-up, her MMSE score had improved to 28\/30, and her mRS score was 1. This case underscores the importance of comprehensive diagnostic approaches and personalized treatment strategies in managing complex cases of mycoplasma-related infections and associated autoimmune conditions.<\/jats:p>","DOI":"10.3389\/fmed.2024.1393540","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:40:26Z","timestamp":1724042426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: a co-occurring case of severe Mycoplasma pneumoniae pneumonia and Anti-IgLON5 antibody-associated encephalitis in a pediatric patient"],"prefix":"10.3389","volume":"11","author":[{"given":"Zimao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuequn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia.","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41479-020-00074-3","article-title":"Etiology of community-acquired pneumonia in adults: A systematic review.","volume":"12","author":"Shoar","year":"2020","journal-title":"Pneumonia."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-019-0469-7","article-title":"Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016.","volume":"8","author":"Zhao","year":"2019","journal-title":"Antimicrob Resis Infect Control."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00576","article-title":"Figural memory impairment in conjunction with neuropsychiatric symptoms in IgLON5 antibody-associated autoimmune encephalitis.","volume":"11","author":"Hansen","year":"2020","journal-title":"Front Psychiatry."},{"key":"B5","article-title":"Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children.","volume":"36","author":"Han","year":"2020","journal-title":"Pak J Med Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00800","article-title":"Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia.","volume":"7","author":"Izumikawa","year":"2016","journal-title":"Front Microbiol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","article-title":"Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010\u20132019.","volume":"120","author":"Lee","year":"2021","journal-title":"J Formosan Med Assoc."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271449","article-title":"Aetiology and prognosis of community-acquired pneumonia at the adult university teaching hospital in Zambia.","volume":"17","author":"Ziko","year":"2022","journal-title":"PLoS One."},{"key":"B9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.21037\/apm.2019.10.05","article-title":"Efficacy of levofloxacin on macrolide-unresponsive and corticosteroid-resistant refractory Mycoplasma pneumoniae pneumonia in children.","volume":"8","author":"Lin","year":"2019","journal-title":"Ann Palliat Med."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105647","article-title":"Cell damage and neutrophils promote the infection of Mycoplasma pneumoniae and inflammatory response.","volume":"169","author":"Zhang","year":"2022","journal-title":"Microb Pathog."},{"key":"B11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14776\/piv.2019.26.e9","article-title":"Child of severe Mycoplasma pneumoniae pneumonia with multiple organ failure treated with ECMO and CRRT.","volume":"26","author":"Hwang","year":"2019","journal-title":"Pediatr Infect Vaccine."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0990-8","article-title":"Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: Meta-analysis of randomized controlled trials.","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Pulmon Med."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1244398","article-title":"Case report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient.","volume":"13","author":"Xu","year":"2023","journal-title":"Front Cell Infect Microbiol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00472","article-title":"Clinical features and inflammatory markers in autoimmune encephalitis associated with antibodies against neuronal surface in Brazilian patients.","volume":"10","author":"N\u00f3brega","year":"2019","journal-title":"Front Neurol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.26241","article-title":"Long-term cognitive outcome in anti\u2013N-Methyl-D-Aspartate receptor encephalitis.","volume":"90","author":"Heine","year":"2021","journal-title":"Ann Neurol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal fluid findings in patients with autoimmune encephalitis\u2013a systematic analysis.","volume":"10","author":"Blinder","year":"2019","journal-title":"Front Neurol."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577999","article-title":"Epileptic seizures in patients with anti-IgLON5 disease.","volume":"373","author":"Wang","year":"2022","journal-title":"J Neuroimmunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1195341","article-title":"Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol."},{"key":"B19","article-title":"Mycoplasma pneumoniae-associated encephalitis: Favorable aggressive immunosuppression in a patient.","author":"Della Giustina","year":"2024","journal-title":"J Pediatr Neurol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1176\/appi.ajp.20230099","article-title":"Recurrent anti-NMDA receptor encephalitis after mycoplasma pneumonia infection.","volume":"180","author":"Dickson","year":"2023","journal-title":"Am J Psychiatry."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000577","article-title":"Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy.","volume":"6","author":"Brunetti","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000522234","article-title":"Anti-IgLON5 encephalopathy with concomitant herpes virus encephalitis.","volume":"29","author":"Wang","year":"2022","journal-title":"Neuroimmunomodulation."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.3988\/jcn.2022.0328","article-title":"Determining the clinical characteristics, treatment strategies, and prognostic factors for Mycoplasma pneumoniae encephalitis in children: A multicenter study in China.","volume":"19","author":"Fan","year":"2023","journal-title":"J Clin Neurol."},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072134","article-title":"Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): A randomised controlled trial.","volume":"13","author":"Hill","year":"2023","journal-title":"BMJ Open."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1195172","article-title":"Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.","volume":"146","author":"Gr\u00fcter","year":"2023","journal-title":"Brain."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106682","article-title":"Low CSF CD4\/CD8+ T-cell proportions are associated with blood\u2013CSF barrier dysfunction in limbic encephalitis.","volume":"102","author":"Hansen","year":"2020","journal-title":"Epilepsy Behav."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.626095","article-title":"How the discovery of the CD4\/CD8-p56lck complexes changed immunology and immunotherapy.","volume":"9","author":"Rudd","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-021-00520-x","article-title":"Clonal expansion of CD4+ CD8+ T cells in an adult patient with Mycoplasma pneumoniae-associated Erythema multiforme majus.","volume":"17","author":"Volkers","year":"2021","journal-title":"Allergy Asthma Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681062","article-title":"Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases.","volume":"12","author":"Horwitz","year":"2021","journal-title":"Front Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1393540\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T20:33:43Z","timestamp":1732653223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1393540\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":30,"alternative-id":["10.3389\/fmed.2024.1393540"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1393540","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"article-number":"1393540"}}